Clayton Associates is an investment firm that is passionate about building businesses.
We make seed, angel, and venture stage investments in healthcare and technology companies.
Recent news from Clayton Associates
StudioNow provides the full spectrum of “Creation to Syndication” empowering companies big and small to create more and do more with their Internet video strategy. They believe that the web will eventually become “one big video” and it is their goal and passion to help their customers obtain and integrate the highest quality resources (creative professionals and technology/software) at the lowest possible cost and time frame.
Over the past few years, StudioNow has dramatically increased their revenue and is raising this investment round to capitalize on the opportunity they are seeing in the market. FCA V’s investment will provide bandwidth to accelerate market growth and hire the key talent needed to scale the company.
Ultimately, the hope is that SureSource will become a large suite of software tools that can streamline data collection at any stage of a clinical trial. In the meantime, hundreds of tablets running SureSource have already been distributed around the world, and the platform is making an immediate impact on the cost of research. Combining greater reliability of trial data with measurable savings, and enabling both novel and neglected use cases, Clinical Ink exemplifies best practices in clinical studies.
“In the face of revenue and reimbursement pressure, it is absolutely critical that hospitals gain control of their operating expenses. By providing hospitals with the means to be more effective purchasers of products and devices they use every day, we can materially reduce the cost of providing care to their patients and thereby improve access to care,” said Hani Elias, CEO of Procured Health. “FCA Venture Partners has demonstrated experience with and commitment to driving efficiency in healthcare, and we are thrilled to be partners with them in our pursuit.”